Thank you, Chair.
For Dr. Beaudet, again, please, when people drop out of clinical trials early on, the researchers call that microdata. Sometimes it's because they're reacting to drugs. I call that life-saving information, and the drug industry sometimes just calls it CBI, confidential business information. This is a big problem for patient safety.
How will the requirement in Vanessa's Law to register all clinical trials change the way you enforce transparency in CIHR-funded trials?